Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

AAM. 2020; 9(4): 256-266


An Experimental Study On Anti venom Activity Of Visha Bilwadi Gutika In Cobra Venom Injected Wistar Albino Rats

Sunitha Gopakumar, Gazala Hussain.




Abstract

Visha Bilwadi Gutika is an herbal formulation mentioned in Kriya Kaumadhi used in snake bite cases in Kerala. In this study, an attempt has been made to explore the therapeutic value and mode of action in Wistar Albino Rats injected with cobra venom. The lyophilised snake venom of cobra was dissolved in saline and administered to rats. The lyophilised polyvalent anti snake venom was used as reference standard drug. The test drug Visha Bilwadi Gutika was evaluated for its efficacy to neutralise the cobra venom by assessing the lethality, haematological, biochemical and histological changes. The venom used in this study was found to have LD50 of 1098μg/kg using OECD 425 protocol. Analysis of the result shows good protection by Visha Bilwadi Gutika against low intensity envenomation. Moderate protection was observed against high dose venom injection in acute conditions. Haematological examination shows significant decrease in RBC, platelets, ALP and cholesterol in comparison to normal control group.

Key words: Visha Bilwadi Gutika, Lyophilised Snake Venom, Polyvalent Anti Snake Venom, kriya kaumadi






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.